ACAD
Acadia Pharmaceuticals Inc. Earnings
$17.81
Earnings Summary
Revenue | $250.4Mn |
Net Profits | $32.77Mn |
Net Profit Margins | 13.09% |
Acadia Pharmaceuticals Inc.’s revenue jumped 18.28% since last year same period to $250.4Mn in the Q3 2024. On a quarterly growth basis, Acadia Pharmaceuticals Inc. has generated 3.49% jump in its revenue since last 3-months.
Acadia Pharmaceuticals Inc.’s net profit jumped 150.27% since last year same period to $32.77Mn in the Q3 2024. On a quarterly growth basis, Acadia Pharmaceuticals Inc. has generated -1.87% fall in its net profits since last 3-months.
Acadia Pharmaceuticals Inc.’s net profit margin jumped 142.5% since last year same period to 13.09% in the Q3 2024. On a quarterly growth basis, Acadia Pharmaceuticals Inc. has generated -5.18% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Acadia Pharmaceuticals Inc. post its latest quarter earningsEPS Estimate Current Year | 0.05 |
Acadia Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.05.
Key Ratios
Key ratios of the Acadia Pharmaceuticals Inc. post its Q3 2024 earningsEarning Per Share (EPS) | 0.2 |
Acadia Pharmaceuticals Inc.’s earning per share (EPS) jumped 150% since last year same period to 0.2 in the Q3 2024. This indicates that the Acadia Pharmaceuticals Inc. has generated 150% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-07 | 0.14 | 0.2 | 42.86% |
2024-08-07 | 0.18 | 0.2 | 11.11% |
2024-05-09 | 0.05 | 0.1 | 100% |
₹0 US Stocks a/c Opening Fee